156 related articles for article (PubMed ID: 1737796)
1. Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination.
Pakdel F; Katzenellenbogen BS
J Biol Chem; 1992 Feb; 267(5):3429-37. PubMed ID: 1737796
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor. Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands.
Reese JC; Katzenellenbogen BS
J Biol Chem; 1991 Jun; 266(17):10880-7. PubMed ID: 2040605
[TBL] [Abstract][Full Text] [Related]
3. William L. McGuire Memorial Symposium. Estrogen receptors: ligand discrimination and antiestrogen action.
Katzenellenbogen BS; Fang H; Ince BA; Pakdel F; Reese JC; Wooge CH; Wrenn CK
Breast Cancer Res Treat; 1993; 27(1-2):17-26. PubMed ID: 8260727
[TBL] [Abstract][Full Text] [Related]
4. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
Montano MM; Müller V; Trobaugh A; Katzenellenbogen BS
Mol Endocrinol; 1995 Jul; 9(7):814-25. PubMed ID: 7476965
[TBL] [Abstract][Full Text] [Related]
5. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
6. Identification of charged residues in an N-terminal portion of the hormone-binding domain of the human estrogen receptor important in transcriptional activity of the receptor.
Pakdel F; Reese JC; Katzenellenbogen BS
Mol Endocrinol; 1993 Nov; 7(11):1408-17. PubMed ID: 8114756
[TBL] [Abstract][Full Text] [Related]
7. Hormone binding and transcription activation by estrogen receptors: analyses using mammalian and yeast systems.
Katzenellenbogen BS; Bhardwaj B; Fang H; Ince BA; Pakdel F; Reese JC; Schodin D; Wrenn CK
J Steroid Biochem Mol Biol; 1993 Dec; 47(1-6):39-48. PubMed ID: 8274440
[TBL] [Abstract][Full Text] [Related]
8. Activation of transcriptionally inactive human estrogen receptors by cyclic adenosine 3',5'-monophosphate and ligands including antiestrogens.
Ince BA; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1994 Oct; 8(10):1397-406. PubMed ID: 7531820
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a temperature-sensitive mutation in the hormone binding domain of the human estrogen receptor. Studies in cell extracts and intact cells and their implications for hormone-dependent transcriptional activation.
Reese JC; Katzenellenbogen BS
J Biol Chem; 1992 May; 267(14):9868-73. PubMed ID: 1577818
[TBL] [Abstract][Full Text] [Related]
10. Powerful dominant negative mutants of the human estrogen receptor.
Ince BA; Zhuang Y; Wrenn CK; Shapiro DJ; Katzenellenbogen BS
J Biol Chem; 1993 Jul; 268(19):14026-32. PubMed ID: 8314770
[TBL] [Abstract][Full Text] [Related]
11. Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens.
Reese JC; Katzenellenbogen BS
Mol Cell Biol; 1992 Oct; 12(10):4531-8. PubMed ID: 1406642
[TBL] [Abstract][Full Text] [Related]
12. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
13. A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.
McInerney EM; Ince BA; Shapiro DJ; Katzenellenbogen BS
Mol Endocrinol; 1996 Dec; 10(12):1519-26. PubMed ID: 8961262
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
Cho H; Katzenellenbogen BS
Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
[TBL] [Abstract][Full Text] [Related]
15. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.
Tremblay GB; Tremblay A; Copeland NG; Gilbert DJ; Jenkins NA; Labrie F; Giguère V
Mol Endocrinol; 1997 Mar; 11(3):353-65. PubMed ID: 9058381
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.
Wrenn CK; Katzenellenbogen BS
J Biol Chem; 1993 Nov; 268(32):24089-98. PubMed ID: 8226955
[TBL] [Abstract][Full Text] [Related]
17. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells.
Weaver CA; Springer PA; Katzenellenbogen BS
Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity.
Le Goff P; Montano MM; Schodin DJ; Katzenellenbogen BS
J Biol Chem; 1994 Feb; 269(6):4458-66. PubMed ID: 8308015
[TBL] [Abstract][Full Text] [Related]
19. Decreased responsiveness of naturally occurring mutants of human estrogen receptor alpha to estrogens and antiestrogens.
Komagata S; Nakajima M; Tsuchiya Y; Katoh M; Kizu R; Kyo S; Yokoi T
J Steroid Biochem Mol Biol; 2006 Jul; 100(1-3):79-86. PubMed ID: 16713253
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-alpha 1 promoter via a novel sequence.
Elgort MG; Zou A; Marschke KB; Allegretto EA
Mol Endocrinol; 1996 May; 10(5):477-87. PubMed ID: 8732679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
